{"title":"Hepatitis C Infection and Chronic Renal Diseases:\nA Systematic Review","authors":"Tara Titian Maulidya, Fauzio Nurul Khaira, Febi Ramdhani Rachman, Reynold Harris Malingkas","doi":"10.17966/jmi.2023.28.2.28","DOIUrl":null,"url":null,"abstract":"A connection was reported between hepatitis C virus (HCV) and chronic kidney disease (CKD). A viral infection can be both a cause and a consequence of CKD. HCV infection is associated with a greater incidence of diabetes mellitus and CKD and a higher risk of systemic (particularly cardiovascular) effects because HCV infection increases the chance of illness developing. Although the fundamental symptom of HCV-induced glomerulonephritis has been well documented, the virus has been related to CKD in various ways, i.e., new evidence points to a connection between HCV infection and CKD onset, as well as the rapid advancement of CKD to end-stage renal disease, which calls for kidney transplantation or hemodialysis. An HCV infection dramatically increased a person's risk of developing CKD, which can lead to kidney failure. Compared with patients with HCV infection and existing CKD, those with HCV infection who had normal renal function had greater odds of renal progression. The administration of anti-hepatitis medication can result in variations in the estimated glomerular filtration rate, which can either lead to an improvement or a worsening of the patient's health, depending on which direction the variation goes.","PeriodicalId":36021,"journal":{"name":"Journal of Mycology and Infection","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Mycology and Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17966/jmi.2023.28.2.28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
A connection was reported between hepatitis C virus (HCV) and chronic kidney disease (CKD). A viral infection can be both a cause and a consequence of CKD. HCV infection is associated with a greater incidence of diabetes mellitus and CKD and a higher risk of systemic (particularly cardiovascular) effects because HCV infection increases the chance of illness developing. Although the fundamental symptom of HCV-induced glomerulonephritis has been well documented, the virus has been related to CKD in various ways, i.e., new evidence points to a connection between HCV infection and CKD onset, as well as the rapid advancement of CKD to end-stage renal disease, which calls for kidney transplantation or hemodialysis. An HCV infection dramatically increased a person's risk of developing CKD, which can lead to kidney failure. Compared with patients with HCV infection and existing CKD, those with HCV infection who had normal renal function had greater odds of renal progression. The administration of anti-hepatitis medication can result in variations in the estimated glomerular filtration rate, which can either lead to an improvement or a worsening of the patient's health, depending on which direction the variation goes.
期刊介绍:
The Journal of mycology and infection (Acronym: JMI, Abbreviation: J Mycol Infect) aims to publish articles of exceptional interests in the field of medical mycology. The journal originally was launched in 1996 as the Korean Journal of Medical Mycology and has reformed into the current state beginning on March of 2018. The contents of the journal should elucidate important microbiological fundamentals and provide qualitative insights to respective clinical aspects. JMI underlines the submission of novel findings and studies in clinical mycology that are enriched by analyses achieved through investigative methods. The journal should be of general interests to the scientific communities at large and should provide medical societies with advanced breadth and depth of mycological expertise. In addition, the journal supplements infectious diseases in adjunct to the field of mycology to address a well-rounded understanding of infectious disorders. The Journal of mycology and infection, which is issued quarterly, in March, June, September and December each year, published in English. The scope of the Journal of mycology and infection includes invited reviews, original articles, case reports, letter to the editor, and images in mycology. The journal is compliant to peer-review/open access and all articles undergo rigorous reviewing processes by our internationally acknowledged team of editorial boards. The articles directed to publication should encompass in-depth materials that employ scholastic values of mycology and various infectious diseases. Articles responding to critical methodology and outcomes which have potential to enhance better understanding of mycology and infectious diseases are also suitable for publication.